• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吉非替尼与大剂量分割放疗用于非小细胞肺癌所致癌性脑炎

Gefitinib and high-dose fractionated radiotherapy for carcinomatous encephalitis from non-small cell lung carcinoma.

作者信息

Wong Eric T, Wu Julian K, Mahadevan Anand

机构信息

Department of Neurology.

出版信息

Biologics. 2007 Sep;1(3):321-4.

PMID:19707341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2721320/
Abstract

Carcinomatous encephalitis is a rapidly fatal form of metastasis caused by miliary spread of systemic cancer into the brain parenchyma. The diagnostic criteria and optimal treatment for this disease are not well defined. We report a patient with rapid neurologic deterioration from carcinomatous encephalitis from lung adenocarcinoma. She was treated with gefitinib and high-dose fractionated whole brain radiotherapy, and eventually improved neurologically and was discharged home on hospital day 48. Gefitinib and high-dose fractionated radiotherapy may have synergistic activity in patients with carcinomatous encephalitis from non-small cell lung cancer having favorable prognostic factors. More importantly, timely recognition of this disease and the use of large fraction radiation therapy are necessary to control rapid neurologic deterioration.

摘要

癌性脑炎是一种由全身性癌症经血行播散至脑实质引起的快速致命性转移形式。该疾病的诊断标准和最佳治疗方法尚不明确。我们报告一名因肺腺癌导致癌性脑炎而出现快速神经功能恶化的患者。她接受了吉非替尼和大剂量分次全脑放疗,最终神经功能得到改善,并于住院第48天出院回家。吉非替尼和大剂量分次放疗可能对具有良好预后因素的非小细胞肺癌所致癌性脑炎患者具有协同活性。更重要的是,及时识别这种疾病并采用大分割放疗对于控制快速神经功能恶化是必要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c242/2721320/9e47551f26dc/btt-1-321f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c242/2721320/319f128691ab/btt-1-321f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c242/2721320/9e47551f26dc/btt-1-321f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c242/2721320/319f128691ab/btt-1-321f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c242/2721320/9e47551f26dc/btt-1-321f2.jpg

相似文献

1
Gefitinib and high-dose fractionated radiotherapy for carcinomatous encephalitis from non-small cell lung carcinoma.吉非替尼与大剂量分割放疗用于非小细胞肺癌所致癌性脑炎
Biologics. 2007 Sep;1(3):321-4.
2
Gefitinib and a ventriculo-peritoneal shunt to manage carcinomatous meningitis from non-small-cell lung cancer: report of two cases.吉非替尼与脑室-腹腔分流术治疗非小细胞肺癌所致癌性脑膜炎:两例报告
Surg Today. 2009;39(7):598-602. doi: 10.1007/s00595-008-3909-1. Epub 2009 Jun 28.
3
Successful treatment of carcinomatous meningitis with gefitinib in a patient with lung adenocarcinoma harboring a mutated EGF receptor gene.吉非替尼成功治疗1例携带表皮生长因子受体(EGF)基因变异的肺腺癌患者的癌性脑膜炎。
Tohoku J Exp Med. 2008 Apr;214(4):359-63. doi: 10.1620/tjem.214.359.
4
Carcinomatous meningitis from non-small-cell lung cancer responding to gefitinib.吉非替尼治疗非小细胞肺癌所致癌性脑膜炎有效
Int J Clin Oncol. 2006 Jun;11(3):243-5. doi: 10.1007/s10147-005-0558-x.
5
Total regression of brain metastases in non-small cell lung cancer patients harboring EGFR mutations treated with gefitinib without radiotherapy: two case reports.吉非替尼治疗非小细胞肺癌脑转移患者(EGFR突变且未行放疗)脑转移灶完全消退:两例报告
BMC Res Notes. 2016 Jan 2;9:2. doi: 10.1186/s13104-015-1834-0.
6
Comparison of Gefitinib versus VMP in the combination with radiotherapy for multiple brain metastases from non-small cell lung cancer.吉非替尼与长春瑞滨联合顺铂对比联合放疗治疗非小细胞肺癌多发脑转移的疗效
Cell Biochem Biophys. 2015 Mar;71(2):1261-5. doi: 10.1007/s12013-014-0286-9.
7
Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer.贝伐单抗和吉非替尼增强了全脑放射治疗对非小细胞肺癌脑转移的疗效。
Braz J Med Biol Res. 2017 Nov 17;51(1):e6073. doi: 10.1590/1414-431X20176073.
8
[Carcinomatous encephalitis].[癌性脑炎]
Medicina (B Aires). 2004;64(6):518-20.
9
[Gefitinib treatment for carcinomatous meningitis in non-small cell lung cancer].吉非替尼治疗非小细胞肺癌癌性脑膜炎
Rev Mal Respir. 2006 Apr;23(2 Pt 1):149-51. doi: 10.1016/s0761-8425(06)71478-4.
10
Miliary brain metastases in 2 cases with advanced non-small cell lung cancer harboring EGFR mutation during gefitinib treatment.2例晚期非小细胞肺癌伴EGFR突变患者在吉非替尼治疗期间发生粟粒性脑转移。
Respir Investig. 2012 Sep;50(3):117-21. doi: 10.1016/j.resinv.2012.06.002. Epub 2012 Jul 15.

引用本文的文献

1
Miliary brain metastasis presenting with calcification in a patient with lung cancer: a case report.肺癌患者出现钙化的粟粒性脑转移:一例报告
J Med Case Rep. 2012 Sep 4;6:279. doi: 10.1186/1752-1947-6-279.

本文引用的文献

1
Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib.一名患有表皮生长因子受体突变和软脑膜转移的非小细胞肺癌患者接受高剂量吉非替尼治疗后的反应与耐药情况
J Clin Oncol. 2006 Sep 20;24(27):4517-20. doi: 10.1200/JCO.2006.06.6126.
2
Encephalopathy in a patient with previous malignancy but normal brain imaging.一名既往有恶性肿瘤病史但脑部影像学检查正常的患者出现脑病。
Neurology. 2005 Jul 12;65(1):165. doi: 10.1212/01.wnl.0000167540.89219.ac.
3
Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence.
表皮生长因子受体基因突变可预测非小细胞肺癌术后复发患者接受吉非替尼治疗后的生存期延长。
J Clin Oncol. 2005 Apr 10;23(11):2513-20. doi: 10.1200/JCO.2005.00.992. Epub 2005 Feb 28.
4
Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib.表皮生长因子受体突变对接受吉非替尼治疗的非小细胞肺癌患者的预测和预后影响。
J Clin Oncol. 2005 Apr 10;23(11):2493-501. doi: 10.1200/JCO.2005.01.388. Epub 2005 Feb 14.
5
Additive interaction of gefitinib ('Iressa', ZD1839) and ionising radiation in human tumour cells in vitro.吉非替尼(“易瑞沙”,ZD1839)与电离辐射在体外人肿瘤细胞中的相加相互作用。
Br J Cancer. 2004 Dec 13;91(12):2026-33. doi: 10.1038/sj.bjc.6602242.
6
Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways.肺癌中使吉非替尼敏感的表皮生长因子受体(EGFR)突变激活抗凋亡途径。
Science. 2004 Aug 20;305(5687):1163-7. doi: 10.1126/science.1101637. Epub 2004 Jul 29.
7
Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer.细支气管肺泡病理亚型和吸烟史可预测晚期非小细胞肺癌对吉非替尼的敏感性。
J Clin Oncol. 2004 Mar 15;22(6):1103-9. doi: 10.1200/JCO.2004.08.158.
8
Encephalitic form of metastatic carcinoma.转移性癌的脑炎性形式。
AMA Arch Neurol Psychiatry. 1951 Feb;65(2):161-73. doi: 10.1001/archneurpsyc.1951.02320020033003.
9
Quality-of-life benefits and evidence of antitumour activity for patients with brain metastases treated with gefitinib.吉非替尼治疗脑转移瘤患者的生活质量获益及抗肿瘤活性证据。
Br J Cancer. 2003 Dec;89 Suppl 2(Suppl 2):S15-8. doi: 10.1038/sj.bjc.6601478.
10
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.表皮生长因子受体酪氨酸激酶抑制剂吉非替尼在有症状的非小细胞肺癌患者中的疗效:一项随机试验。
JAMA. 2003 Oct 22;290(16):2149-58. doi: 10.1001/jama.290.16.2149.